The forecast indicates a slight and consistent decrease in malignant neoplasms mortality rates among men in Brazil from 2024 to 2028, starting from a rate of 115.2 deaths per hundred thousand men in 2024, declining to 114.7 by 2028. This suggests a modest year-on-year reduction in mortality rates of approximately 0.2% annually.
Future trends to watch for include advances in cancer treatment technology, public health initiatives aiming to reduce risk factors associated with cancer, and changes in healthcare infrastructure in Brazil. These factors could potentially accelerate the decline in mortality rates, provided they are effectively implemented and accessible across the region.
